Eli Lilly Fights Counterfeit Mounjaro and Ozempic in Pharmacies
TL;DR
Eli Lilly has filed lawsuits against six entities, including medical spas and wellness centers, for selling counterfeit versions of its diabetes drug Mounjaro, which contains tirzepatide. The company warns that these unapproved versions pose safety risks to patients. Demand for GLP-1 drugs, including Mounjaro, has been high, leading to limited availability. The FDA has also cautioned against the use of compounded versions of these drugs.
- Lilly files more lawsuits to curb sales of counterfeit Mounjaro Reuters
- Fake Weight Loss Drugs: What To Know As Eli Lilly Plans Lawsuits Against Mounjaro, Zepbound Counterfeiters Forbes
- 'They're entering pharmacies': How counterfeit Ozempic entered the 'legitimate drug supply' MSNBC
- Readout Newsletter: Eli Lilly, Sarepta, Alnylam Pharma news STAT
- Medical Product Alert N°2/2024: Falsified OZEMPIC (semaglutide) World Health Organization (WHO)
Want the full story? Read the original reporting
Read on Reuters